S. 1096, titled the “Preserve Access to Affordable Generics and Biosimilars Act,” aims to stop brand name and generic drug companies from making deals that delay cheaper generic drugs from entering the market. The bill also addresses similar deals regarding biological medicines and their more...
Simple Explanation
This bill wants to make sure that brand name and cheaper generic drug companies, as well as makers of biological medicines, play fair and don't make secret deals that keep cheaper drugs out of stores. It's like stopping some companies from paying others to keep kids from having more choices in their toy store.